logo-loader
RNS
viewSativa Group PLC

Sativa Group PLC - Significant Contract with Alliance Healthcare

RNS Number : 5499B
Sativa Group PLC
31 January 2020
 

Press Release 

 

31st January 2020

 

 

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014.  Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

 

Sativa Group Plc

 

("Sativa" or "the Company" or "the Group")

 

Goodbody Botanicals signs deal with Alliance Healthcare

for product distribution to UK Pharmacies

 

Sativa Group Plc subsidiary Goodbody Botanicals has secured a product listing agreement with Alliance Healthcare ("Alliance"), one of the leading distributors and wholesalers of pharmaceutical, medical and healthcare products in the UK and Europe.  This gives Alliance's 10,000+ high street retailer customers access to the Goodbody Botanicals range of market-leading CBD products.  Alliance Healthcare services independent pharmacies, national accounts, and superstores. 

 

In addition, Alliance's syndicated pharmacy salesforce, Skills in Healthcare, has been contracted to promote and sell the Goodbody Botanicals range to the 1,500 top performing independent pharmacy customers.  

 

Sativa Chief Executive Henry Lees-Buckley said: "The Alliance distribution agreement is a significant step in Sativa's Goodbody Botanicals CBD Wellness brand's objective to grow market share with high street pharmacies, grocers, and superstores." 

 

Media enquiries. 

Abchurch Communications

Julian Bosdet

+44 (0)207 4594 4070 

+44 (0) 7771 663 886 

[email protected]

www.abchurch-group.com

 

 

For further information please contact: 

 

Henry Lees-Buckley 

Chief Executive Officer

Sativa Group Plc 

+44 (0) 20 7971 1255

 

[email protected]

www.sativagroup.co.uk

Joseph Colliver

Chief Financial Officer

Sativa Group Plc 

+44 (0) 20 7971 1255

 

[email protected] 

www.sativagroup.co.uk

NEX Exchange Corporate Adviser

 

Corporate Finance 

Stephen Keys / Max Gould 

Cenkos Securities plc 

+44 (0) 20 7397 8900

 

 

Equity Sales 

Julian Morse

Cenkos Securities

+44 (0) 20 7397 8900

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
NEXUARBRRWUAORR

Quick facts: Sativa Group PLC

Price: 2.85

Market: NEX
Market Cap: -
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Sativa Investments PLC acquires UK-based PhytoVista Laboratories

Geremy Thomas, chief executive of Sativa Investments PLC (NEX:SATI), tells Proactive's Andrew Scott they've agreed to buy PhytoVista Laboratories, a UK-based lab that tests cannabis oils and hemp products, for £435,000. The British medicinal cannabis investment vehicle will pay £235,000...

on 4/7/18